Please enable Javascript on your browser for a better experience.
The Atherosclerosis Risk & Advanced Cardiometabolic Panel provides an in-depth cardiovascular evaluation by measuring cholesterol, ApoB, Lipoprotein (a), HbA1c, fasting insulin, inflammation, metabolic function, and blood counts. This comprehensive screening helps identify traditional and advanced risk markers linked to arterial plaque development and long-term heart health.
Comprehensive GLP-1 metabolic monitoring panel including Hemoglobin A1c, fasting glucose, insulin, lipid panel, hs-CRP, and full metabolic panel with liver enzymes, kidney markers, and electrolytes. Designed to support baseline assessment and ongoing monitoring of glycemic control, insulin resistance, cardiometabolic risk, and organ function during GLP-1–based therapy.
The Atherosclerotic Risk Screening Panel evaluates key cardiovascular risk markers including cholesterol, blood sugar control, metabolic function, and inflammation. By combining a Lipid Panel, Hemoglobin A1c, Comprehensive Metabolic Panel, and hs-CRP, this comprehensive assessment helps identify factors linked to arterial plaque development and long-term heart health.
Comprehensive panel evaluating cardiac strain, myocardial injury, kidney function, metabolic balance, and glycemic control. Measures NT-proBNP, high-sensitivity Troponin T, A1c, CMP, CBC, and urinary albumin to assess the systemic impact of vascular aging and cardiometabolic stress. Designed for structured end-organ surveillance and proactive cardiovascular health monitoring.
Evaluate metabolic health and insulin sensitivity with the Visceral Fat and Insulin Resistance Panel. This panel includes glucose, insulin, lipid, inflammation, and liver markers to provide insight into visceral fat related metabolic function, energy regulation, and cardiometabolic risk factors.
The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.
The Troponin I Test measures levels of cardiac troponin I in blood to help diagnose heart attack, myocardial injury, and acute coronary syndrome. Elevated levels indicate heart muscle damage from blocked arteries, inflammation, or other cardiac stress. Doctors order this test for patients with chest pain, shortness of breath, or suspected heart disease. Results provide critical insight for early detection, treatment decisions, and ongoing heart health monitoring.
A comprehensive heart health blood test panel designed to help detect hidden cardiovascular risk by measuring inflammation, advanced lipid markers, inherited heart disease risk, blood sugar, and wellness biomarkers. This panel goes beyond a standard cholesterol test with hs-CRP, CRP, ApoB, Lipoprotein(a), Cardio IQ™ Ion Mobility, A1c, fasting glucose, CBC, CMP, and ferritin to support preventive heart health and deeper blood tests for heart disease.
Inflammation and Heart Disease Comprehensive Risk Panel, Blood Tests for Heart Disease Panel, Comprehensive Heart Risk & Inflammation Panel, Advanced Heart Risk & Inflammation Panel, Hidden Heart Risk Blood Test Panel
Assess key metabolic markers linked to visceral fat with the Visceral Fat Foundation Panel. This panel includes a Comprehensive Metabolic Panel, Lipid Panel, and Hemoglobin A1c to provide insight into glucose regulation, cholesterol levels, liver function, and overall metabolic health.
The Methylation Essentials Panel provides a comprehensive baseline evaluation of core laboratory markers involved in the body’s methylation process. Methylation is a fundamental biochemical pathway that supports nutrient metabolism, cardiovascular wellness, energy production, and cellular maintenance.
The Sports Performance & Recovery Panel — Comprehensive evaluates key biomarkers that influence training adaptation, recovery, and athletic performance. By measuring muscle stress, inflammation, iron status, cortisol, testosterone, thyroid hormones, RBC magnesium, vitamin D, and comprehensive metabolic markers, this panel provides a data-driven view of how the body responds to physical stress and supports performance optimization.
Comprehensive heart and metabolic screening for women. This advanced panel evaluates cholesterol, ApoB, Lipoprotein (a), inflammation (hs-CRP), blood sugar control, insulin, thyroid function, vitamin D, ferritin, and overall metabolic health. Designed to support proactive cardiovascular risk assessment and long-term metabolic wellness with clinically relevant biomarkers in one integrated blood test panel.
The GLP-1 Basic Blood Test Panel provides a comprehensive baseline for metabolic health by evaluating glucose control, insulin levels, lipids, thyroid function, organ health, and blood cell markers. Designed to support GLP-1–related monitoring and preventive care, this panel delivers clinically relevant insights that help patients and healthcare providers understand metabolic trends, assess risk, and track changes over time.
Gain advanced insight into metabolic, cardiovascular, and hormonal health with the Visceral Fat and Cardiometabolic Optimization Advanced Panel. This panel evaluates glucose, insulin, lipids, inflammation, liver enzymes, advanced lipoproteins, thyroid markers, and sex hormones to provide a comprehensive view of visceral fat related cardiometabolic function.
A comprehensive women’s hormone-driven heart risk panel evaluating cortisol, DHEA-S, estradiol, progesterone, FSH, LH, testosterone, SHBG, full thyroid function with antibodies, glucose, and insulin. Designed to assess how adrenal, ovarian, thyroid, and metabolic hormones influence cardiovascular and cardiometabolic health during hormonal transitions.
Advanced GLP-1 metabolic monitoring panel including A1c, glucose, insulin, C-peptide, ApoB, Lipoprotein (a), lipid panel, hs-CRP, homocysteine, kidney function (Cystatin C, eGFR, urine albumin), liver enzymes, vitamin B12, vitamin D, and magnesium. Designed for comprehensive cardiometabolic and renal monitoring during GLP-1–based therapy.